135 related articles for article (PubMed ID: 33185160)
1. The Involvement of the Mammalian Target of Rapamycin, Protein Tyrosine Phosphatase 1b and Dipeptidase 4 Signaling Pathways in Cancer and Diabetes: A Narrative Review.
Zhang J; Wu N; Shi D
Mini Rev Med Chem; 2021; 21(7):803-815. PubMed ID: 33185160
[TBL] [Abstract][Full Text] [Related]
2. mTOR Signaling in Growth, Metabolism, and Disease.
Saxton RA; Sabatini DM
Cell; 2017 Mar; 168(6):960-976. PubMed ID: 28283069
[TBL] [Abstract][Full Text] [Related]
3. Eicosapentaenoic acid abolishes inhibition of insulin-induced mTOR phosphorylation by LPS via PTP1B downregulation in skeletal muscle.
Wei HK; Deng Z; Jiang SZ; Song TX; Zhou YF; Peng J; Tao YX
Mol Cell Endocrinol; 2017 Jan; 439():116-125. PubMed ID: 27984084
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in PTP1B signaling in metabolism and cancer.
Villamar-Cruz O; Loza-Mejía MA; Arias-Romero LE; Camacho-Arroyo I
Biosci Rep; 2021 Nov; 41(11):. PubMed ID: 34726241
[TBL] [Abstract][Full Text] [Related]
5. Protein Tyrosine Phosphatase 1B (PTP1B): Insights into its New Implications in Tumorigenesis.
Chen PJ; Zhang YT
Curr Cancer Drug Targets; 2022; 22(3):181-194. PubMed ID: 35088671
[TBL] [Abstract][Full Text] [Related]
6. mTOR signaling in stem and progenitor cells.
Meng D; Frank AR; Jewell JL
Development; 2018 Jan; 145(1):. PubMed ID: 29311260
[TBL] [Abstract][Full Text] [Related]
7. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice.
Gum RJ; Gaede LL; Koterski SL; Heindel M; Clampit JE; Zinker BA; Trevillyan JM; Ulrich RG; Jirousek MR; Rondinone CM
Diabetes; 2003 Jan; 52(1):21-8. PubMed ID: 12502489
[TBL] [Abstract][Full Text] [Related]
8. Beyond the metabolic function of PTP1B.
Dubé N; Tremblay ML
Cell Cycle; 2004 May; 3(5):550-3. PubMed ID: 15044856
[TBL] [Abstract][Full Text] [Related]
9. Protein tyrosine phosphatase 1B (PTP1B) and obesity.
Cho H
Vitam Horm; 2013; 91():405-24. PubMed ID: 23374726
[TBL] [Abstract][Full Text] [Related]
10. Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases.
Kaur A; Sharma S
Inflammopharmacology; 2017 Jun; 25(3):293-312. PubMed ID: 28417246
[TBL] [Abstract][Full Text] [Related]
11. Deletion of protein tyrosine phosphatase 1B rescues against myocardial anomalies in high fat diet-induced obesity: Role of AMPK-dependent autophagy.
Kandadi MR; Panzhinskiy E; Roe ND; Nair S; Hu D; Sun A
Biochim Biophys Acta; 2015 Feb; 1852(2):299-309. PubMed ID: 25018087
[TBL] [Abstract][Full Text] [Related]
12. Mammalian target of rapamycin signaling in diabetic cardiovascular disease.
Chong ZZ; Maiese K
Cardiovasc Diabetol; 2012 Jul; 11():45. PubMed ID: 22545721
[TBL] [Abstract][Full Text] [Related]
13. [Role of protein tyrosine phosphatase 1B in the type 2 diabetes and obesity].
Wang C; Wang L; Yang Z
Yi Chuan; 2004 Nov; 26(6):941-6. PubMed ID: 15640130
[TBL] [Abstract][Full Text] [Related]
14. PTP1B: a double agent in metabolism and oncogenesis.
Yip SC; Saha S; Chernoff J
Trends Biochem Sci; 2010 Aug; 35(8):442-9. PubMed ID: 20381358
[TBL] [Abstract][Full Text] [Related]
15. [Research progress of several protein tyrosine phosphatases in diabetes].
Chen M; Sun JP; Liu J; Yu X
Sheng Li Xue Bao; 2010 Apr; 62(2):179-89. PubMed ID: 20401454
[TBL] [Abstract][Full Text] [Related]
16. Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus.
Nandi S; Saxena M
Curr Top Med Chem; 2020; 20(29):2692-2707. PubMed ID: 32888269
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the development of protein tyrosine phosphatase 1B inhibitors for Type 2 diabetes.
Qian S; Zhang M; He Y; Wang W; Liu S
Future Med Chem; 2016 Jul; 8(11):1239-58. PubMed ID: 27357615
[TBL] [Abstract][Full Text] [Related]
18. [TOR-centric concept of regulation mitogenic, metabolic and energetic signal processing in cell].
Zubova SG; Shitikova ZhV; Pospelova TV
Tsitologiia; 2012; 54(8):589-602. PubMed ID: 23074850
[TBL] [Abstract][Full Text] [Related]
19. [Effect of AMPK/mTOR/S6K1 pathways and the insulin-sensitizing effect for adiponectin in endometrial cancer cells].
Cai ZF; Deng L; Wang MM; Zhang JQ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2018 Aug; 53(8):554-560. PubMed ID: 30138966
[No Abstract] [Full Text] [Related]
20. mTOR in aging, metabolism, and cancer.
Cornu M; Albert V; Hall MN
Curr Opin Genet Dev; 2013 Feb; 23(1):53-62. PubMed ID: 23317514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
